Aurobindo Pharma gains 10% in three days on USFDA approval

Shares of Aurobindo Pharma jumped once again on Monday by 2%, gaining almost 10% in three trading sessions. The shares were last trading at Rs 130.75 on the Bombay Stock Exchange.

Aurobindo Pharma has been rising ever since the company secured final approval from the USFDA to manufacture & market Amlodipine Besylate and Benazepril Hydrochloride Capsules.

The company is an integrated pharma company, which features among the top 10 companies in India in terms of consolidated revenues.
Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations.

GoodReturns.in